← SynDRA
CEP-37440
SynDRA canonical compound SYN0038663 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ALK |
|---|
| Mechanism of action | ALK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ALK INHIBITOR
- ALK tyrosine kinase receptor inhibitor
- PTK2 INHIBITOR
- Focal adhesion kinase 1 inhibitor
- PTK2 MODULATOR
Cross-references
Synonyms
- Alk-fak inhibitor cep-37440
- Dual ALK/FAK inhibitor (cancer), Cephalon
- Dual anaplastic lymphoma kinase/focal adhesion kinase inhibitor (cancer),Cephalon
- Alk-fak inhibitor CEP-37440
- O3MNS8782H
- RefChem:124349
- UNII-O3MNS8782H
- MFCD28009441
- GTPL9698
- SCHEMBL15269443
- SCHEMBL29354193
- SCHEMBL29489150
- CEP37440
- EX-A1543
- RFC71260
- BDBM50193811
- NSC781148
- NSC800983
- AKOS027337463
- CEP-37440?
- NSC-781148
- NSC-800983
- compound 27b [PMID: 27527804]
- NCGC00378557-02
- NCGC00378557-03
- NCGC00378557-07
- AC-36010
- HY-15841
- NS00073434
- F13321
- C179603
- BRD-K72827473-001-01-0
- 2N1592JH39
- UNII-2N1592JH39
- CEP-37440 trihydrochloride dihydrate
Look up CEP-37440 in the interactive SynDRA portal →